APA (7th ed.) Citation

Weisz, G., Généreux, P., Iñiguez, A., Zurakowski, A., Shechter, M., Alexander, K. P., . . . Stone, G. W. (2016). Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial. The Lancet (British edition), 387(10014), 136-145. https://doi.org/10.1016/S0140-6736(15)00459-6

Chicago Style (17th ed.) Citation

Weisz, Giora, et al. "Ranolazine in Patients with Incomplete Revascularisation After Percutaneous Coronary Intervention (RIVER-PCI): A Multicentre, Randomised, Double-blind, Placebo-controlled Trial." The Lancet (British Edition) 387, no. 10014 (2016): 136-145. https://doi.org/10.1016/S0140-6736(15)00459-6.

MLA (9th ed.) Citation

Weisz, Giora, et al. "Ranolazine in Patients with Incomplete Revascularisation After Percutaneous Coronary Intervention (RIVER-PCI): A Multicentre, Randomised, Double-blind, Placebo-controlled Trial." The Lancet (British Edition), vol. 387, no. 10014, 2016, pp. 136-145, https://doi.org/10.1016/S0140-6736(15)00459-6.